Article Details
Retrieved on: 2025-03-06 11:49:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The monoclonal antibodies ... The expiration of patents for key biologics has accelerated the adoption of biosimilar monoclonal antibodies, and the cost ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here